Table: Jcr Pharmaceuticals -Q1 group results

JCR Pharmaceuticals

30/07/2026 07:32

    Jul 30 (Reuters)- 
             Jcr Pharmaceuticals Co., Ltd. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2026        Jun 30, 2025     Mar 31, 2027 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             9.70                8.57             45.70    
                 (+13.2 pct)         (+5.2 pct)       (+13.3 pct) 
  Operating       loss 2.10         loss 606 mln          1.10    
                                                      (+98.2 pct) 
  Recurring       loss 2.08         loss 749 mln        500 mln   
                                                      (-57.1 pct) 
  Net             loss 1.91         loss 546 mln        200 mln   
                                                      (-90.8 pct) 
  EPS          loss 15.64 yen       loss 4.48 yen      1.64 yen   
  Ann Div                             20.00 yen        20.00 yen  
  -Q2 div                             10.00 yen        10.00 yen  
  -Q4 div                             10.00 yen        10.00 yen  
  
  NOTE - Jcr Pharmaceuticals Co., Ltd.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4552.T